Psoriasis Treatment in Thiruvalla
Expert Care for Plaque Psoriasis & Scalp Psoriasis
Psoriasis is manageable — not permanent suffering. DermaVue Thiruvalla offers medically supervised care from topicals to biologics so you can live comfortably.
Understanding Psoriasis: Immunology, Classification & Severity Assessment
Quick Answer
Psoriasis treatment in Thiruvalla/Tiruvalla is severity-stratified using PASI, BSA and DLQI: mild disease managed with potent topical corticosteroids and calcipotriol; moderate-to-severe disease treated with NB-UVB phototherapy, methotrexate, apremilast, or oral deucravacitinib; severe or PASI-10+ disease with IL-17 (secukinumab, ixekizumab), IL-23 (guselkumab, risankizumab) or TNF-alpha (adalimumab) biologics. Psoriatic arthritis screening uses the PEST questionnaire and CASPAR criteria.
DermaVue Clinical Summary — Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory disease characterised by hyperproliferation of keratinocytes driven by a dysregulated IL-23/Th17 axis. Dendritic cell IL-23 production activates Th17 lymphocytes to produce IL-17A, IL-17F and IL-22, which in turn drive keratinocyte hyperplasia and the clinical appearance of well-demarcated, silver-scaled plaques. Genetic susceptibility loci include HLA-Cw6 and variants in IL23R and CARD14. Clinical types include plaque psoriasis (~85% of cases), guttate (often post-streptococcal), inverse (intertriginous — aggravated by Kerala humidity), erythrodermic, pustular (palmoplantar and generalised von Zumbusch), nail psoriasis, and psoriatic arthritis.
Severity at DermaVue Thiruvalla is documented using the Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA) and Dermatology Life Quality Index (DLQI). Psoriatic arthritis — present in up to 30% of psoriasis patients — is screened at every visit using the PEST questionnaire and confirmed against the CASPAR criteria (Taylor et al., Arthritis Rheum 2006). The Koebner phenomenon (appearance of new lesions at sites of skin trauma) informs lifestyle counselling. Treatment follows the IADVL psoriasis consensus, the AAD/NPF joint guidelines (Menter et al., JAAD 2019–2020), and the European S3 guideline.
First-line topical therapy comprises potent corticosteroids (betamethasone, clobetasol), vitamin D3 analogues (calcipotriol), fixed combinations (calcipotriol + betamethasone foam and gel), and scalp preparations. Narrow-band UVB phototherapy (311–313 nm) is offered as a well-validated second-line intervention. Systemic options include methotrexate with folic acid rescue, cyclosporine, acitretin, apremilast (PDE4 inhibitor), and oral deucravacitinib (first-in-class TYK2 inhibitor, approved on the POETYK PSO-1 and PSO-2 trials, Armstrong et al., JAAD 2023). Modern biologics include adalimumab, secukinumab (IL-17A), ixekizumab (IL-17A), brodalumab (IL-17RA), guselkumab (IL-23p19) and risankizumab (IL-23p19) — the IL-23 class delivering the highest PASI 100 response rates across head-to-head trials (Reich et al., Lancet 2019). DermaVue Thiruvalla respects patient interest in complementary Ayurveda but counsels that evidence-review critique of many advertised "psoriasis cure" programmes identifies absent randomised trial data, uncontrolled outcomes, and occasional undisclosed steroid content in herbal preparations (IJDVL editorials 2019–2022). Sources: IADVL (iadvl.org), IJDVL, AAD, NEJM, PubMed, NIH.
- Plaque psoriasis — most common, elbows, knees, scalp, trunk
- Scalp psoriasis — often confused with severe dandruff
- Guttate psoriasis — small drop-like lesions, often post-infection
- Inverse psoriasis — skin folds, worsened by high humidity
- Pustular psoriasis — sterile pus-filled blisters
- Nail psoriasis — pitting, onycholysis
- Psoriatic arthritis — joint involvement requiring coordinated care
Understanding Psoriasis — Causes & Treatment
Psoriasis Treatment Options at DermaVue Thiruvalla
Treatment is tailored to psoriasis severity, affected body surface area, and response to prior therapies. We start with the least aggressive effective option and escalate when needed.
- Potent topical corticosteroids — correctly dosed and rotated
- Vitamin D analogues: calcipotriol alone or combined with steroid
- Coal tar preparations for scalp and body plaques
- Narrow-band UVB phototherapy — 2–3 sessions/week for 8–12 weeks
- Systemic agents: methotrexate, cyclosporine, acitretin
- Biologics (adalimumab, secukinumab, ixekizumab) for moderate–severe psoriasis
- Scalp psoriasis: medicated shampoos, topical solutions, intralesional steroids
Ready to Book Your Psoriasis Treatment in Thiruvalla?
DermaVue Thiruvalla — Iykara Peniel Tower, Opposite Indian Overseas Bank, Thukalassery. Mon–Sat 9 AM–7 PM, Sun 10 AM–6 PM.
Psoriasis Medication — Important Safety Guidance
Frequently Asked Questions
Book Your Consultation at DermaVue Thiruvalla
Board-certified dermatologists. Hospital-standard OT. US-FDA approved equipment. Physician-led care — not technician-run.
What Our Patients Say
Real experiences from patients across our 7 clinics.
Visited this clinic for my skin concerns, and I'm extremely satisfied with the treatment. The doctor is knowledgeable and patient.
The skin treatment at DermaVue was excellent. The consultation was detailed, and the treatment plan was explained thoroughly.
Best dermatology clinic I've been to. The facilities are world-class and the results from my laser treatment exceeded expectations.
Visit Us at Any of Our 7 Clinics
Internationally certified dermatology care across Kerala and Tamil Nadu.